VRNS SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Varonis Systems, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit!

NEW YORK CITY, NY / ACCESS Newswire / February 3, 2026 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Varonis Systems, Inc. (NASDAQ:VRNS) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the […]

GoldQuest Provides Update on Drilling and Exploration Activities at Romero Gold-Copper Project, Dominican Republic

Vancouver, British Columbia–(Newsfile Corp. – February 3, 2026) – GoldQuest Mining Corp. (TSXV: GQC) (OTCQX: GDQMF) (“GoldQuest” or the “Company“) is pleased to provide an update on its ongoing 2025-2026 drilling and metallurgical testwork program at the 100%-owned Romero Gold-Copper Project in the Dominican Republic. The Company has successfully completed the metallurgical drill program: 5

BellRing Brands Announces Leadership Transition Plan

(NYSE:BRBR), ST. LOUIS, Feb. 03, 2026 (GLOBE NEWSWIRE) — BellRing Brands, Inc. (NYSE:BRBR) (the “Company”) today announced that its President and Chief Executive Officer Darcy Davenport has decided to retire from the Company, effective upon the earlier of the appointment of a new Chief Executive Officer or September 30, 2026, the end of the Company's

Invivyd Aligns with the U.S. FDA on LIBERTY, a Phase 3 Trial to Evaluate the Safety of VYD2311 Antibody Versus mRNA COVID Vaccine, and to Characterize the Safety and Immunology of Antibody and Vaccine Co-Administration

(NasdaqGM:IVVD), LIBERTY is part of the Company's broader REVOLUTION clinical program designed to elaborate the profile of monoclonal antibody-mediated prophylaxis from COVID-19 and the potential medical benefits to vulnerable Americans The LIBERTY clinical trial will evaluate comparative safety and immunology of VYD2311 versus mRNA COVID vaccine, as well as explore the safety and immunology of

CBD Life Sciences Inc. (CBDL) Announces Smoking Scholars Bronx Dispensary as Major Distributor for High-Demand Dubai Mushroom Chocolate

With the global functional mushroom market projected to exceed $30+ billion and forecasted to grow at an estimated 9-12% CAGR, this strategic Bronx, New York distribution expansion positions CBDL to capture accelerating consumer demand, drive repeat retail velocity, and unlock scalable, high-margin revenue channels. SCOTTSDALE, ARIZONA / ACCESS Newswire / February 3, 2026 / CBD

PayPal Reports Fourth Quarter and Full Year 2025 Results

PayPal Holdings, Inc. (NASDAQ: PYPL) today announced its fourth quarter and full year 2025 results for the period ended December 31, 2025. The earnings release and related materials discussing these results can be found on PayPal's investor relations website at https://investor.pypl.com/financials/quarterly-results/default.aspx. PayPal Holdings, Inc. will host a conference call to discuss these results at 5:00

CLEUF INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that China Liberal Education Holdings Ltd. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

NEW YORK CITY, NY / ACCESS Newswire / February 3, 2026 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against China Liberal Education Holdings Ltd. (OTCMKTS:CLEUF) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations

METC INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Ramaco Resources, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

NEW YORK CITY, NY / ACCESS Newswire / February 3, 2026 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Ramaco Resources, Inc. (NASDAQ:METC) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the

EV Nickel Reports Strong Pilot-Scale Bioleach Results With Over 90% Nickel Extraction And Successful Nickel Sulphate Production

90.1% Ni and 89.6% Co extraction achieved at day six Pilot circuit operated continuously for 11 days, followed by 5 days of batch operation >99% recovery of Ni and Co as a mixed hydroxide precipitate ("MHP") from pregnant leach solution Successful precipitated Nickel sulphate (NiSOâ??·6Hâ??O) with a purity of up to 98.2% Effective iron removal

VTGN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Vistagen Therapeutics, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit!

NEW YORK CITY, NY / ACCESS Newswire / February 3, 2026 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Vistagen Therapeutics, Inc. (NASDAQ:VTGN) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the

Scroll to Top